Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma

BACKGROUND: In patients with advanced hepatocellular carcinoma (HCC), combination chemotherapy using 5- fluorouracil, cisplatin, and mitoxantrone (FMP) could achieve a response rate > 20%, but the beneficial effect was compromised by formidable adverse events. Chemotherapy given in a split-dose m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Chau-Ting, Chen, Hui-Chin, Sung, Chang-Mu, Hsu, Cheng-Lung, Lin, Chen-Chun, Pan, Kuang-Tse, Tseng, Jeng-Hwei, Hung, Chien-Fu
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079691/
https://www.ncbi.nlm.nih.gov/pubmed/21453495
http://dx.doi.org/10.1186/1471-2407-11-117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079691/
https://www.ncbi.nlm.nih.gov/pubmed/21453495
http://dx.doi.org/10.1186/1471-2407-11-117

Ejemplares similares